| [1] |
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia[J]. Lancet, 2005, 365(9461): 785-799.
|
| [2] |
Duley L. The global impact of preeclampsia and eclampsia[J]. Semin Perinatol, 2009, 33(3): 130-137.
|
| [3] |
谢幸，苟文丽，主编. 妇产科学.8版[M]．北京：人民卫生出版社，2013: 130-137.
|
| [4] |
Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia[J]. Semin Fetal Neonatal Med, 2006, 11(5): 309-316.
|
| [5] |
Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview[J]. Reprod Biomed Online, 2006, 13(5): 680-686.
|
| [6] |
Robertson WB, Brosens I, Pijnenborg R, et al. The making of the placental bed[J]. Eur J Obstet Gynecol Reprod Biol, 1984, 18(5-6): 255-266.
|
| [7] |
Roberts JM, Gammill HS. Preeclampsia: recent insights[J]. Hypertension, 2005, 46(6): 1243-1249.
|
| [8] |
Kovo M, Schreiber L, Ben-Haroush A, et al. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction[J]. Am J Obstet Gynecol, 2010, 202(6): 561.e1-e5.
|
| [9] |
Aharon A, Brenner B. Microparticles and pregnancy complications[J]. Thromb Res, 2011, 127(Suppl 3): S67-S71.
|
| [10] |
Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy[J]. Am J Obstet Gynecol, 1999, 180(2 Pt 1): 499-506.
|
| [11] |
Bowen JM, Chamley L, Mitchell MD, et al. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women[J]. Placenta, 2002, 23(4): 239-256.
|
| [12] |
Chaouat G, Assal MA, Martal J, et al. IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau[J]. J Immunol, 1995, 154(9): 4261-4268.
|
| [13] |
Yui J, Garcia-Lloret M, Wegmann TG, et al. Cytotoxicity of tumor necrosis factor-α (TNF-α) and gamma-interferon (IFN-γ) against primary human placental trophoblasts[J]. Placenta, 1994, 15(8): 819-828.
|
| [14] |
Austgulen R, Lien E, Liabakk NB, et al. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 1994, 57(3) ：149-155.
|
| [15] |
Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy[J]. Diabetes, 2002, 51(7): 2207-2213.
|
| [16] |
Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1：Th2 cell ratio during normal human pregnancy and preeclampsia[J]. Clin Exp Immunol, 1999, 117(3): 550-555.
|
| [17] |
Szarka A, Rigó J Jr, Lázár L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array[J]. BMC Immunol, 2010, 11(1): 59.
|
| [18] |
Rein DT, Schondorf T, Gohring UJ, et al. Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsia[J]. J Reprod Immunol, 2002, 54(1-2): 133-142.
|
| [19] |
Sakai M, Tsuda H, Tanebe K, et al. Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients[J]. Am J Reprod Immunol, 2002, 47(2): 91-97.
|
| [20] |
Jonsson Y, Matthiesen L, Berg G, et al. Indications of an altered immune balance in preeclampsia: a decrease in in vitro secretion of IL-5 and IL-10 from blood mononuclear cells and in blood basophil counts compared with normal pregnancy[J]. J Reprod Immunol, 2005, 66(1): 69-84.
|
| [21] |
Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia[J]. Br J Obstet Gynaecol, 1995, 102(10): 20-25.
|
| [22] |
Kalantar F, Rajaei S, Heidari AB, et al. Serum levels of tumor necrosis factor-α，interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women[J]. Iran J Nurs Midwifery Res, 2013, 18(6): 463-466.
|
| [23] |
Lau SY, Guild SJ, Barrett CJ, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and Meta-analysis[J]. Am J Reprod Immunol, 2013, 70(5): 412-427.
|
| [24] |
Xie C, Yao MZ, Liu JB, et al. A Meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia[J]. Cytokine, 2011, 56(3): 550-559.
|
| [25] |
Taylor DJ, Phillips P, Lind T. Puerperal haematological indices[J]. Br J Obstet Gynaecol, 1981, 88(6): 601-606.
|
| [26] |
Luppi P, Haluszczak C, Trucco M, et al. Normal pregnancy is associated with peripheral leukocyte activation[J]. Am J Reprod Immunol, 2002, 47(2): 72-81.
|
| [27] |
Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis[J]. Am J Obstet Gynecol, 1998, 179(1): 80-86.
|
| [28] |
Mellembakken JR, Aukrust P, Olafsen MK, et al. Activation of leukocytes during the uteroplacental passage in preeclampsia[J]. Hypertension, 2002, 39(1): 155-160.
|
| [29] |
Aly AS, Khandelwal M, Zhao J, et al. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia[J]. Am J Obstet Gynecol, 2004, 190(1): 252-258.
|
| [30] |
Tsukimori K, Fukushima K, Tsushima A, et al. Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies[J]. Hypertension, 2005, 46(2): 696-700.
|
| [31] |
Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004, 303(5663): 1532-1535.
|
| [32] |
Black S, Kushner I, Samols D. C-reactive protein[J]. J Biol Chem, 2004, 279(47): 48487-48490.
|
| [33] |
Saks GP, Seyani L, Lavery S, et al. Maternal C-reactive protein levels are raised at 4 weeks of gestation[J]. Hum Reprod, 2004, 19(4): 1025.
|
| [34] |
Kumru S, Godekmerdan A, Kutlu S, et al. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and chemical parameters in preeclampsia[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 124(2): 164-167.
|
| [35] |
Belo L, Santos-Silva A, Caslake M, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia[J]. Hypertens Pregnancy, 2003, 22(2): 129-141.
|
| [36] |
Tjoa ML, Van Vugt JM, Go AT, et al. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction[J]. J Reprod Immunol, 2003, 59(1): 29-37.
|
| [37] |
Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation[J]. Obstet Gynecol, 2001, 98(5 Pt 1): 757-762.
|
| [38] |
Malek A, Bersinger NA, Di Santo S, et al. Creactive protein production in term human placental tissue[J]. Placenta, 2006, 27(6-7): 619-625.
|
| [39] |
Romero R, Kusanovic JP, Chaiworapongsa T, et al. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae[J]. Best Pract Res Clin Obstet Gynaecol, 2011, 25(3): 313-327.
|
| [40] |
Giasson J, Li GH, Chen Y. Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non-acute kidney injury (AKI) diseases[J]. Inflamm Allergy Drug Targets, 2011, 10(4): 272-282.
|
| [41] |
Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL，a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993, 268(14): 10425-10432.
|
| [42] |
D′Anna R, Baviera G, Giordano D, et al. First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia[J]. Prenat Diagn, 2009, 29(11): 1066-1068.
|
| [43] |
D′Anna R, Baviera G, Giordano D, et al. Second trimester neutrophil gelatinase associated lipocalin as a potential prediagnostic marker of preeclampsia[J]. Acta Obstet Gynecol Scand, 2008, 87(12): 1370-1373.
|
| [44] |
D′Anna R, Baviera G, Giordano D, et al. Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia[J]. Acta Obstet Gynecol Scand, 2010, 89(2): 275-278.
|
| [45] |
Simonazzi G, Capelli I, Curti A, et al. Serum and urinary neutrophil gelatinase-associated lipocalin monitoring in normal pregnancy versus pregnancies complicated by pre-eclampsia[J]. In Vivo, 2015, 29(1): 117-121.
|
| [46] |
Kim SM, Park JS, Norwitz ER, et al. Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia[J]. Reprod Sci, 2013, 20(9): 1083-1089.
|
| [47] |
Karampas G, Eleftheriades M, Panoulis K, et al. Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate: a longitudinal study[J]. Prenat Diagn, 2014, 34(8): 726-733.
|
| [48] |
Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition[J]. Mol Cell, 2002, 10(5): 1033-1043.
|
| [49] |
须静，胡晓波. 中性粒细胞明胶酶相关脂质运载蛋白的研究进展[J]．检验医学，2012, 27(10): 871-876.
|